The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial

The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial

Abstract Background We performed a multicenter, randomized open-label trial in patients with moderate to severe Covid-19 treated with a range of possible treatment regimens. Methods: Patients were randomly assigned to one of three regimen groups at a ratio of 1:1:1. The primary outcome of this study...

Full description

Bibliographic Details
Main Authors: Mostafa Ghanei, Masoud Solaymani-Dodaran, Ali Qazvini, Amir Hosein Ghazale, Seyed Amin Setarehdan, Seyed Hassan Saadat, Hassan Ghobadi, Saeed Hoseininia, Maryam Elahikhah, Ali Hossein Samadi, Yousef Imani, Ensieh Vahedi, Farhang Babamahmoodi, Fatemeh Tajik Rostami, Mohammad Hossein Azimzadeh Ardebili, Akram Ansarifar, Fatemeh Fallahpoor Golmaei, Atieh Asadollah
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Respiratory Research
Subjects:
COVID-19
Corticosteroids
Low dose prednisolone
Anti-inflammatory drugs
Online Access:https://doi.org/10.1186/s12931-021-01833-6

Internet

https://doi.org/10.1186/s12931-021-01833-6

Similar Items